Acurx Pharmaceuticals's total assets for Q1 2024 were $9.11M, an increase of 18.16% from the previous quarter. ACXP total liabilities were $3.11M for the fiscal quarter, a 2.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.